Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Fujisawa Investments for Entrepreneurship

Inactive STATUS

Fujisawa Investments for Entrepreneurship was a venture capital firm based in Evanston, Illinois. The firm made investments in the early stage bio-medical and pharmaceutical companies.

Investor Status
Out of Business
Year Founded
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
  • 1801 Maple Avenue
  • Evanston, IL 60201
  • United States

Fujisawa Investments for Entrepreneurship Investments (8)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Renovar 30-Nov-2006 Early Stage VC 00.00 Monitoring Equipment Out of Business
000000 01-May-2005 00000 00000 Biotechnology Profitable
000000 00000000000 19-Dec-2003 0000 000.00 Biotechnology Generating Revenue
0000000 00000000 06-Jun-2002 00000000000 00.000 Biotechnology Product Development
000000000000 30-Jan-2001 0000 00000 000 Drug Discovery Out of Business 00000000 000000000 00.0
0000000 0000000000 01-Jan-2001 00000 00000 Biotechnology Out of Business
Artecel Sciences 29-Nov-2000 Early Stage VC 000 Biotechnology Product Development
Fennec Pharmaceuticals 01-Jan-2000 Early Stage VC 00000 Biotechnology Generating Revenue
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Fujisawa Investments for Entrepreneurship’s full profile, request a free trial.

Fujisawa Investments for Entrepreneurship Exits (5)

Company Name Exit Date Exit Type Exit Size Status Buyers
Renovar 01-Oct-2013 Out of Business Completed
000000 12-Nov-2009 000000000000000000 000.00 Completed
  • 00000 0000000
0000000 0000000000 01-Oct-2002 0000000000: 000000 Completed
Artecel Sciences Bankruptcy: Liquidation Completed
Neuronautics Bankruptcy: Liquidation Completed
To view this investor’s complete exits history, request access »